Current status:
Cancelled Post Market
Current status date:
2001-09-19
Product name:
METHOTREXATE-LIQ IM IV IAR INT IVR 25MG/ML
DIN:
02170663
Electronic product monograph is not available
Route(s) of administration:
Intra-Arterial
,
Intrathecal
,
Intramuscular
,
Intravenous
Number of active ingredient(s):
1
Schedule(s):
Prescription
Anatomical Therapeutic Chemical (ATC):
See footnote 4
L01BA01 METHOTREXATE
List of active ingredient(s)
Active ingredient(s)
See footnote8
|
Strength |
METHOTREXATE (METHOTREXATE SODIUM)
|
25 MG / ML
|